BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 20692026)

  • 1. Prescribing practices and asthma control with hydrofluoroalkane-beclomethasone and fluticasone: a real-world observational study.
    Price D; Martin RJ; Barnes N; Dorinsky P; Israel E; Roche N; Chisholm A; Hillyer EV; Kemp L; Lee AJ; von Ziegenweidt J; Colice G
    J Allergy Clin Immunol; 2010 Sep; 126(3):511-8.e1-10. PubMed ID: 20692026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A fixed combination of fluticasone and salmeterol permits better control of asthma than a beclomethasone dipropionate and montelukast combination].
    Grosclaude M; Cerruti JL; Delannay B; Hérent M; Spilthooren F; Desfougères JL
    Eur Ann Allergy Clin Immunol; 2003 Nov; 35(9):356-62. PubMed ID: 14716965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma.
    Pearlman DS; Stricker W; Weinstein S; Gross G; Chervinsky P; Woodring A; Prillaman B; Shah T
    Ann Allergy Asthma Immunol; 1999 Mar; 82(3):257-65. PubMed ID: 10094216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Asthma: the role of fluticasone propionate.
    Br J Hosp Med; 1997 Dec; 58(11):555-64. PubMed ID: 10193470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Which inhaled corticosteroid for asthma?
    Wilson SA
    J Fam Pract; 1999 Sep; 48(9):658-9. PubMed ID: 10498062
    [No Abstract]   [Full Text] [Related]  

  • 6. A randomized, double-blind comparison of beclomethasone dipropionate extrafine aerosol and fluticasone propionate.
    Fairfax A; Hall I; Spelman R
    Ann Allergy Asthma Immunol; 2001 May; 86(5):575-82. PubMed ID: 11379810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beclometasone dipropionate extrafine aerosol versus fluticasone propionate in children with asthma.
    van Aalderen WM; Price D; De Baets FM; Price J
    Respir Med; 2007 Jul; 101(7):1585-93. PubMed ID: 17254760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Considering therapeutic options in the real world.
    Martin RJ
    J Allergy Clin Immunol; 2003 Nov; 112(5 Suppl):S112-5. PubMed ID: 14586396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Observational study of the effects of using montelukast vs fluticasone in patients matched at baseline.
    Allen-Ramey FC; Duong PT; Riedel AA; Markson LE; Weiss KB
    Ann Allergy Asthma Immunol; 2004 Oct; 93(4):373-80. PubMed ID: 15521374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resource utilization in asthma: combined fluticasone propionate/salmeterol compared with inhaled corticosteroids.
    Friedman HS; Yawn BP
    Curr Med Res Opin; 2007 Feb; 23(2):427-34. PubMed ID: 17288696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose inhaled corticosteroids and the prevention of death from asthma.
    Suissa S; Ernst P; Benayoun S; Baltzan M; Cai B
    N Engl J Med; 2000 Aug; 343(5):332-6. PubMed ID: 10922423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does measuring BHR add to guideline derived clinical measures in determining treatment for patients with persistent asthma?
    Koenig SM; Murray JJ; Wolfe J; Andersen L; Yancey S; Prillaman B; Stauffer J; Dorinsky P
    Respir Med; 2008 May; 102(5):665-73. PubMed ID: 18328683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose inhaled fluticasone does not replace oral prednisolone in children with mild to moderate acute asthma.
    Schuh S; Dick PT; Stephens D; Hartley M; Khaikin S; Rodrigues L; Coates AL
    Pediatrics; 2006 Aug; 118(2):644-50. PubMed ID: 16882819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential prescribing of inhaled corticosteroids in New Zealand general practice.
    Hall J; Penrose A; Tomlin A; Reid J
    N Z Med J; 2003 Aug; 116(1180):U563. PubMed ID: 14581985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of obesity on response to fluticasone with or without salmeterol in moderate asthma.
    Boulet LP; Franssen E
    Respir Med; 2007 Nov; 101(11):2240-7. PubMed ID: 17686624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Addition of montelukast or salmeterol to fluticasone for protection against asthma attacks: a randomized, double-blind, multicenter study.
    Ilowite J; Webb R; Friedman B; Kerwin E; Bird SR; Hustad CM; Edelman JM
    Ann Allergy Asthma Immunol; 2004 Jun; 92(6):641-8. PubMed ID: 15237766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term comparison of 3 controller regimens for mild-moderate persistent childhood asthma: the Pediatric Asthma Controller Trial.
    Sorkness CA; Lemanske RF; Mauger DT; Boehmer SJ; Chinchilli VM; Martinez FD; Strunk RC; Szefler SJ; Zeiger RS; Bacharier LB; Bloomberg GR; Covar RA; Guilbert TW; Heldt G; Larsen G; Mellon MH; Morgan WJ; Moss MH; Spahn JD; Taussig LM;
    J Allergy Clin Immunol; 2007 Jan; 119(1):64-72. PubMed ID: 17140647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tapering inhaled steroids effective for chronic asthma.
    See S; Rubin S
    J Fam Pract; 2003 Oct; 52(10):748-51. PubMed ID: 14529591
    [No Abstract]   [Full Text] [Related]  

  • 19. [Fluticasone propionate in children and infants with asthma].
    Marchac V; Foussier V; Devillier P; Le Bourgeois M; Polak M
    Arch Pediatr; 2007 Apr; 14(4):376-87. PubMed ID: 17289359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effectiveness and safety of fluticasone propionate in therapy of children suffering from asthma. Part I. Mechanisms of actions and clinical effectiveness of treatment in children with asthma].
    Bartkowiak-Emeryk M; Breborowicz A; Emeryk A; Kulus M; Kurzawa R; Lis G; Mazurek H; Niedziela M
    Pol Merkur Lekarski; 2004; 17 Suppl 2():5-10. PubMed ID: 15688663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.